A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.

Animals C9orf72 Protein Cactaceae Camelus Frontotemporal Dementia / complications Humans Progranulins Semantics
C9orf72 MAPT frontotemporal dementia genetics progranulin semantic knowledge

Journal

Applied neuropsychology. Adult
ISSN: 2327-9109
Titre abrégé: Appl Neuropsychol Adult
Pays: United States
ID NLM: 101584082

Informations de publication

Date de publication:
Historique:
pubmed: 7 2 2020
medline: 21 1 2022
entrez: 7 2 2020
Statut: ppublish

Résumé

Impaired semantic knowledge is a characteristic feature of some forms of frontotemporal dementia (FTD), particularly the sporadic disorder semantic dementia. Less is known about semantic cognition in the genetic forms of FTD caused by mutations in the genes

Identifiants

DOI: 10.1080/23279095.2020.1716357 PMID: 32024404
pubmed: 32024404
doi: 10.1080/23279095.2020.1716357
doi:

Substances chimiques

C9orf72 Protein 0
Progranulins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-119

Subventions

Organisme : Medical Research Council
ID : MC_U123160651
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105597119
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J009482/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M023664/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K010395/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008525/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M018288/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00005/12
Pays : United Kingdom

Auteurs

Katrina Moore (K)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0002-4458-8390

Rhian Convery (R)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0002-9477-1812

Martina Bocchetta (M)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0003-1814-5024

Mollie Neason (M)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0001-9419-7171

David M Cash (DM)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.

Caroline Greaves (C)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0002-6446-1960

Lucy L Russell (LL)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0001-5023-5893

Mica T M Clarke (MTM)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0003-0570-4296

Georgia Peakman (G)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0002-3319-138X

John van Swieten (J)

Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.

Lize Jiskoot (L)

Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.

Fermin Moreno (F)

Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Spain.

Myriam Barandiaran (M)

Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Spain.

Raquel Sanchez-Valle (R)

Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Robert Laforce (R)

Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada.

Marie-Claire Doré (MC)

Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada.

Mario Masellis (M)

Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.

Maria Carmela Tartaglia (MC)

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.

Caroline Graff (C)

Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.

Daniela Galimberti (D)

Centro Dino Ferrari, University of Milan, Milan, Italy.
Neurodegenerative Diseases Unit, Ospedale Policlinico, Fondazione IRCCS Ca' Granda, Milan, IT.
ORCID: 0000-0002-9284-5953

James B Rowe (JB)

Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Elizabeth Finger (E)

Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Hans-Otto Karnath (HO)

Division of Neuropsychology, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.

Rik Vandenberghe (R)

Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Alexandre de Mendonça (A)

Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Carolina Maruta (C)

Faculty of Medicine, Laboratory of Language Research, Centro de Estudos Egas Moniz, University of Lisbon, Lisbon, Portugal.

Fabrizio Tagliavini (F)

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologica Carlo Besta, Milano, Italy.

Isabel Santana (I)

Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Simon Ducharme (S)

Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Canada.

Chris Butler (C)

Department of Clinical Neurology, University of Oxford, Oxford, UK.

Alex Gerhard (A)

Faculty of Medical and Human Sciences, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.

Johannes Levin (J)

Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.

Adrian Danek (A)

Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.

Markus Otto (M)

Department of Neurology, University of Ulm, Ulm, Germany.
ORCID: 0000-0003-4273-4267

Jason D Warren (JD)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.

Jonathan D Rohrer (JD)

Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
ORCID: 0000-0002-6155-8417

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Régulateurs des protéines G › Facteurs d'échange de nucléotides guanyliques › Protéine C9orf72 › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Caryophyllanae › Caryophyllales › Cactaceae › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Camelidae › Chameaux › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Dégénérescence lobaire frontotemporale › Démence frontotemporale › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Progranulines › A modified Camel and Cactus Test detects...
questionsmedicales.fr › Sciences de l'information › Langage › Linguistique › Sémantique › A modified Camel and Cactus Test detects...